398 related articles for article (PubMed ID: 26541825)
1. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
2. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
3. The role of the DEAD-box RNA helicase DDX3 in mRNA metabolism.
Soto-Rifo R; Ohlmann T
Wiley Interdiscip Rev RNA; 2013; 4(4):369-85. PubMed ID: 23606618
[TBL] [Abstract][Full Text] [Related]
4. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
5. DEAD-box RNA helicase DDX3 connects CRM1-dependent nuclear export and translation of the HIV-1 unspliced mRNA through its N-terminal domain.
Fröhlich A; Rojas-Araya B; Pereira-Montecinos C; Dellarossa A; Toro-Ascuy D; Prades-Pérez Y; García-de-Gracia F; Garcés-Alday A; Rubilar PS; Valiente-Echeverría F; Ohlmann T; Soto-Rifo R
Biochim Biophys Acta; 2016 May; 1859(5):719-30. PubMed ID: 27012366
[TBL] [Abstract][Full Text] [Related]
6. (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.
Wang X; Wang R; Luo M; Li C; Wang HX; Huan CC; Qu YR; Liao Y; Mao X
Oncotarget; 2017 May; 8(20):33197-33213. PubMed ID: 28402257
[TBL] [Abstract][Full Text] [Related]
7. Analog sensitive chemical inhibition of the DEAD-box protein DDX3.
Floor SN; Barkovich KJ; Condon KJ; Shokat KM; Doudna JA
Protein Sci; 2016 Mar; 25(3):638-49. PubMed ID: 26650549
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity.
Valiente-Echeverría F; Hermoso MA; Soto-Rifo R
Rev Med Virol; 2015 Sep; 25(5):286-99. PubMed ID: 26174373
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of threonine 204 of DEAD-box RNA helicase DDX3 by cyclin B/cdc2 in vitro.
Sekiguchi T; Kurihara Y; Fukumura J
Biochem Biophys Res Commun; 2007 May; 356(3):668-73. PubMed ID: 17379183
[TBL] [Abstract][Full Text] [Related]
10. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation.
Schröder M
Biochem Pharmacol; 2010 Feb; 79(3):297-306. PubMed ID: 19782656
[TBL] [Abstract][Full Text] [Related]
11. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export.
Choi YJ; Lee SG
J Cell Biochem; 2012 Mar; 113(3):985-96. PubMed ID: 22034099
[TBL] [Abstract][Full Text] [Related]
12. The Ded1/DDX3 subfamily of DEAD-box RNA helicases.
Sharma D; Jankowsky E
Crit Rev Biochem Mol Biol; 2014; 49(4):343-60. PubMed ID: 25039764
[TBL] [Abstract][Full Text] [Related]
13. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.
Shih JW; Tsai TY; Chao CH; Wu Lee YH
Oncogene; 2008 Jan; 27(5):700-14. PubMed ID: 17667941
[TBL] [Abstract][Full Text] [Related]
14. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
15. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
16. DDX3 RNA helicase is required for HIV-1 Tat function.
Yasuda-Inoue M; Kuroki M; Ariumi Y
Biochem Biophys Res Commun; 2013 Nov; 441(3):607-11. PubMed ID: 24183723
[TBL] [Abstract][Full Text] [Related]
17. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
18. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.
Doneti R; Pasha A; Botlagunta M; Heena SK; Mutyala VVVP; Pawar SC
Med Oncol; 2022 Sep; 39(11):179. PubMed ID: 36048256
[TBL] [Abstract][Full Text] [Related]
20. The prognostic effect of DDX3 upregulation in distant breast cancer metastases.
Heerma van Voss MR; Schrijver WA; Ter Hoeve ND; Hoefnagel LD; Manson QF; van der Wall E; Raman V; van Diest PJ;
Clin Exp Metastasis; 2017 Jan; 34(1):85-92. PubMed ID: 27999982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]